Early response assessment and prediction of overall survival after peptide receptor radionuclide therapy

被引：0
|
作者：
Huizing, D. [1 ]
Aalbersberg, E. A. [1 ]
Versleijen, M. W. J. [1 ]
Tesselaar, M. E. T. [1 ]
Walraven, I. [1 ]
Lahaye, M. J. [1 ]
de Wit-van der Veen, B. J. [1 ]
Stokkel, M. P. M. [1 ]
机构：
[1] Netherlands Canc Inst, Amsterdam, Netherlands
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2020年 / 47卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-276
引用
收藏
页码：S140 / S141
页数：2
相关论文
共 50 条
  • [21] Prediction of relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy
    Lapa, Constantin
    Werner, Rudolf
    Brumberg, Joachim
    Biko, Johannes
    Schirbel, Andreas
    Bluemel, Christina
    Bundschuh, Ralph
    Buck, Andreas
    Schneider, Peter
    Herrmann, Ken
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [22] Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy
    Rudolf A. Werner
    Harun Ilhan
    Sebastian Lehner
    László Papp
    Norbert Zsótér
    Imke Schatka
    Dirk O. Muegge
    Mehrbod S. Javadi
    Takahiro Higuchi
    Andreas K. Buck
    Peter Bartenstein
    Frank Bengel
    Markus Essler
    Constantin Lapa
    Ralph A. Bundschuh
    Molecular Imaging and Biology, 2019, 21 : 582 - 590
  • [23] Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy
    Werner, Rudolf A.
    Ilhan, Harun
    Lehner, Sebastian
    Papp, Laszlo
    Zsoter, Norbert
    Schatka, Imke
    Muegge, Dirk O.
    Javadi, Mehrbod S.
    Higuchi, Takahiro
    Buck, Andreas K.
    Bartenstein, Peter
    Bengel, Frank
    Essler, Markus
    Lapa, Constantin
    Bundschuh, Ralph A.
    MOLECULAR IMAGING AND BIOLOGY, 2019, 21 (03) : 582 - 590
  • [24] Advances in Peptide Receptor Radionuclide Therapy
    Sabet, Amir
    Biersack, Hans-Juergen
    Ezziddin, Samer
    SEMINARS IN NUCLEAR MEDICINE, 2016, 46 (01) : 40 - 46
  • [25] Therapy-related myeloid neoplasm after peptide receptor radionuclide therapy (PRRT) in 1631 patients from our 20 years of experiences: prognostic parameters and overall survival
    M. Chantadisai
    H. R. Kulkarni
    R. P. Baum
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 1390 - 1398
  • [26] Peptide Receptor Radionuclide Therapy for Sarcoidosis
    Lapa, Constantin
    Grigoleit, Goetz Ulrich
    Haenscheid, Heribert
    Klinker, Erdwine
    Jung, Pius
    Herrmann, Ken
    Schirbel, Andreas
    Boeck, Markus
    Buck, Andreas K.
    Pelzer, Theo
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 194 (11) : 1428 - 1430
  • [27] Peptide Receptor Radionuclide Therapy: An Overview
    Dash, Ashutosh
    Chakraborty, Sudipta
    Pillai, Maroor Raghavan Ambikalmajan
    Knapp, Furn F. , Jr.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2015, 30 (02) : 47 - 71
  • [28] Therapy-related myeloid neoplasm after peptide receptor radionuclide therapy (PRRT) in 1631 patients from our 20 years of experiences: prognostic parameters and overall survival
    Chantadisai, M.
    Kulkarni, H. R.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (05) : 1390 - 1398
  • [29] A Case of Metastatic VIPoma With Complete Response to Peptide Radionuclide Receptor Therapy
    Audil, Hadiyah Y.
    Eiring, Rachel A.
    Kendi, A. Tuba
    Halfdanarson, Thorvardur R.
    PANCREAS, 2021, 50 (04) : E45 - E46
  • [30] 68Ga-DOTATATE PET/CT for the early prediction of response to peptide receptor radionuclide therapy in patients with well differentiated neuroendocrine tumours
    Haug, Alexander
    Auernhammer, Christoph
    Waengler, Bjoern
    Schmidt, Gerwin
    Cumming, Paul
    Bartenstein, Peter
    Hacker, Marcus
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
12345